The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project

NCT07112365 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Dravet Syndrome

Interventions

DRUG: Fenfluramine treatment (Fintepla)
DEVICE: Hypercapnia Challenge using the device (RespirAct)

Sponsor

The University of Texas Health Science Center, Houston